Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of UCN-01 in Combination With Topotecan in Patients With Solid Tumors

NCT00045175 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00045175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00045175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of UCN-01 in Combination With Topotecan in Patients With Solid Tumors
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2002
Completion date
Not reported
Enrollment
33 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, ovarian cancer, primary peritoneal cavity cancer